Search the Newsreel

Moderna, Inc. Revenue Breakdown – BX:0QF

Moderna, Inc. (0QF) generated 1.54 billion CHF last year, predominantly from its Messenger RNA (mRNA) Medicines segment. This marks a decrease from the previous year's 2.94 billion CHF for the same segment. The United States was the largest contributor to revenue, accounting for 950.53 …

Modular Medical Inc (MODD) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Modular Medical Inc (MODD), listing major individual and institutional holders. It provides a breakdown of shareholder types, institutional holdings over several quarters, and recent shareholder activity, including changes in holdings by specific firms. The data shows key …

Inmode Ltd (INMD) Income Statement

Is Now The Time To Look At Buying Modine Manufacturing Company (NYSE:MOD)?

NULL

Modern Dental Group Limited Revenue Breakdown – HKEX:3600

Paradigm Capital Management Inc. NY Has $315.44 Million Stake in Modine Manufacturing Company $MOD

Paradigm Capital Management Inc. NY has reported a minor reduction in its stake in Modine Manufacturing Company (NYSE:MOD) during the first quarter, now holding 1,455,598 shares valued at $315.44 million, making it their largest investment. Other institutional investors like Invesco Ltd. and Price T …

Modine Manufacturing Company $MOD Shares Bought by Granahan Investment Management LLC

Granahan Investment Management LLC increased its stake in Modine Manufacturing Company by 15.7% in the first quarter, making it their fourth-largest holding. The auto parts company beat expected quarterly earnings and revenue, with analysts maintaining a "Moderate Buy" consensus rating and an average price …

Inmode Ltd (INMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Inmode Ltd (INMD), detailing its financial performance by region. It highlights that in the most recent disclosed period, the United States accounted for 53.62% of revenue, followed by Europe with 21.33% and Asia with 13.28%. The article …

Inmode Ltd (INMD) Institutional Confidence

This article analyzes the institutional confidence in Inmode Ltd (INMD), noting its current institutional shareholding score of 5.00, which ranks 108th in the Healthcare Equipment & Supplies industry. The institutional shareholding proportion has decreased by 9.31% quarter-over-quarter to 53.60%. James Simons is identified as …

INMD Q1 2026 Earnings: EPS Misses Estimates by 17.4%, Stock Reacts Mildly - ROIC Trend Report

Modine Manufacturing Company Revenue Breakdown – NYSE:MOD

Modine Manufacturing Company (NYSE: MOD) generated $3.18 billion USD in total revenue last year. Its Climate Solutions segment was the top performer, contributing $2.06 billion USD, a significant increase from the previous year. The United States was the largest geographical contributor, accounting for $1.68 …

Moderna: A Stock to Watch or a Risky Bet?

This article features a Motley Fool Scoreboard episode discussing Moderna (NASDAQ: MRNA) to help investors gain insights into market trends and potential opportunities. While experts analyze Moderna, the article also highlights other investment recommendations from Motley Fool's Stock Advisor, noting Moderna was not among …

Moderna Inc (MRNA) Institutional Confidence

Moderna Inc (MRNA) has an institutional shareholding score of 7.00, placing it 50th out of 155 in the pharmaceuticals industry. The institutional shareholding proportion recently increased by 3.46% quarter-over-quarter, now standing at 78.90%. Fidelity Management & Research Company LLC, BlackRock Institutional Trust Company, N.A., …

Moderna stock may move 4.2% on July 31 earnings release By Investing.com

Moderna Inc. (MRNA) stock is projected to move 4.2% around its July 31 earnings release, according to options data. Historically, the stock has exceeded its implied move in three of the last eight earnings announcements. Notably, its largest post-earnings move in the past two …

Moderna Inc (MRNA) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Moderna Inc (MRNA), detailing its current earnings forecast score, analyst ratings, and price targets. It includes expected revenue for the next quarter, past and future EPS, and a peer comparison within the Pharmaceuticals industry. The majority of …

Baillie Gifford (MRNA) discloses 18.2M Moderna shares in latest 13G/A

Baillie Gifford & Co has filed Amendment No. 7 to a Schedule 13G/A, reporting its passive ownership in Moderna, Inc. As of June 30, 2026, the firm beneficially owned 18,206,778 shares of Moderna common stock, which represents 4.59% of the outstanding shares. This filing …

Will Moderna (MRNA) Report Negative Earnings Next Week? What You Should Know

Moderna (MRNA) is expected to report a year-over-year increase in earnings on lower revenues for the quarter ended June 2026, with an estimated loss of $1.97 per share. Despite a positive year-over-year change in earnings, the Zacks Earnings ESP for Moderna is -2.41%, combined …

Illinois Municipal Retirement Fund Trims Holdings in Modine Manufacturing Company $MOD

The Illinois Municipal Retirement Fund significantly reduced its stake in Modine Manufacturing Company by 55.6% during the first quarter, selling 4,096 shares and retaining 3,266 shares valued at $708,000. Despite this institutional selling and some insider transactions, Modine Manufacturing reported strong Q1 earnings and …

Moderna (MRNA) Stock Looks Above Fair Value After Cancer Trial News

Moderna (MRNA) stock has seen an 84.8% return year-to-date, but its current valuation, with a P/S ratio of 10.2x against a tailored P/S of 2.6x, suggests it is overvalued. Despite progress in its cancer program and flu vaccine, the stock's high price reflects investor …

Moderna (MRNA) Projected to Post Earnings on Friday

Moderna (MRNA) is projected to announce its Q2 2026 earnings before the market opens on Friday, July 31st. Analysts expect a loss of ($2.00) per share on revenue of approximately $103.1 million. The company's prior quarter widely beat revenue estimates but still posted a …

Why Modine (MOD) Is Up 10.3% After Landing a Multi‑Year Data Center Capacity Deal

Modine Manufacturing (MOD) saw its stock rise by 10.3% following the announcement of a multi-year, multi-billion dollar data center capacity agreement through 2029, and the appointment of Michael Mahan as President of its new Commercial HVAC segment. The deal, valued at over US$4 billion …

INMD|Inmode Ltd|Price:15.095|Chg%:-0.105

Inmode Ltd (INMD) has a relatively healthy fundamental outlook and high growth potential, with its valuation considered fairly valued within the Healthcare Equipment & Supplies industry. Institutional ownership is high, though it decreased by 35.22% quarter-over-quarter. Analysts currently rate the stock as a Hold …

Gentherm (NASDAQ: THRM) details Modine SpinCo merger, guidance raise and Q2 2026 metrics

Gentherm reported strong Q2 2026 results, with product revenue of $416.2M and 9.5% year-over-year growth, leading to a raise in its 2026 guidance. The company also detailed its proposed strategic combination with Modine’s Performance Technologies business (SpinCo), which is expected to expand its thermal …

Gentherm (THRM) raises 2026 guidance and targets $3.5B revenue with Modine combination

Gentherm (THRM) raised its 2026 guidance, now targeting $1.6 billion in revenue and $185-$200 million in adjusted EBITDA, following strong second-quarter performance with product revenue up 11% year-over-year. The company also detailed its planned combination with Modine’s Performance Technologies business, projecting the combined entity …

Modular Medical Forms Pivot Innovation Council, Appoints Diabetes Expert Dr. Robert Gabbay as Chair

Modular Medical Inc. (NASDAQ: MODD) has established the Pivot Innovation Council and appointed internationally recognized diabetes expert Dr. Robert Gabbay as its inaugural chairman. This council will guide the company's clinical and commercial strategy, evidence generation, product roadmap, and commercialization efforts for its Pivot™ …

Modular Medical (MODD) Establishes Pivot Innovation Council to Enhance Diabetes Care

Modular Medical (MODD) has established a Pivot Innovation Council, chaired by Dr. Robert Gabbay, to advance its diabetes care initiatives. This strategic move aims to improve clinical workflows, refine product strategy for insulin pumps, and address the growing demand in the healthcare market. Despite …

Modine (MOD) Reports Next Week: Wall Street Expects Earnings Growth

Modine (MOD) is projected to announce a year-over-year increase in both earnings and revenue for the quarter ending June 2026. Despite the positive revenue outlook, the Zacks Earnings ESP for Modine is -10.15%, suggesting analysts have become more bearish on its EPS prospects, making …

Modular Medical Announces Formation of Pivot Innovation Council and Appointment of Robert Gabbay, MD, PhD, FACP as Chairman

Modular Medical, Inc. (NASDAQ: MODD) has announced the formation of its Pivot Innovation Council and the appointment of Robert Gabbay, MD, PhD, FACP as its chairman. This council comprises leading clinicians and healthcare experts and will provide strategic clinical guidance for the commercialization, patient …

Modular Medical council focuses on a simpler insulin pump experience

Modular Medical (NASDAQ: MODD) has formed the Pivot Innovation Council, appointing Robert Gabbay, MD, PhD, FACP, as its chairman. This council comprises clinicians and healthcare experts who will guide the clinical and commercial strategy for the company's Pivot™ tubeless patch pump. The aim is …

CI Investments Inc. Purchases New Position in Modine Manufacturing Company $MOD

CI Investments Inc. has acquired a new position in Modine Manufacturing Company (NYSE:MOD), purchasing 74,712 shares valued at approximately $16.2 million in the first quarter. Institutional investors now collectively own about 95.23% of Modine's stock, with several other firms also increasing their stakes. Despite …

Earnings Preview: What To Expect From Moderna’s Report

Modine Gears Up to Report Q1 Earnings: What's in the Cards?

Modine Manufacturing Company (MOD) is set to announce its first-quarter fiscal 2027 results on July 29, with analysts projecting an EPS of $1.38 and revenues of $895.51 million, indicating significant year-over-year growth. The company's strong data center business and strategic agreements are expected to …

Southernsun Asset Management LLC Has $23.90 Million Position in Modine Manufacturing Company $MOD

Southernsun Asset Management LLC significantly reduced its stake in Modine Manufacturing Company by 55.6% in the first quarter, yet the company remains its 16th largest position, valued at $23.9 million. Modine Manufacturing has seen recent insider selling totaling approximately $15.9 million, but analysts generally …

Himension Capital Singapore PTE. LTD. Cuts Position in Moderna, Inc. $MRNA

Himension Capital Singapore PTE. LTD. reduced its stake in Moderna, Inc. by 38.8% in Q1, selling 22,390 shares and holding stock worth $1.795 million. Despite this, other institutions like PNC Financial Services Group Inc., Commerzbank Aktiengesellschaft FI, AlTi Global Inc., Meeder Advisory Services Inc., …

Himension Capital Singapore PTE. LTD. Takes Position in Modine Manufacturing Company $MOD

Himension Capital Singapore PTE. LTD. has purchased a new stake of 8,467 shares, valued at approximately $1,835,000, in Modine Manufacturing Company during the first quarter. This comes as several institutional investors have modified their holdings, with institutional ownership of Modine Manufacturing standing at 95.23%. …

Moderna Rabies Vaccine Candidate by Moderna Inc. - mRNA approach in early trials

Moderna Inc. is developing an mRNA-based rabies vaccine candidate, which is currently in early clinical development as a prophylactic. This vaccine uses mRNA technology to trigger an immune response against the rabies virus, potentially offering a more flexible and faster development process compared to …